CORVALLIS, Ore., May 8, 2025 /PRNewswire/ -- Karma Biosciences announced today that it has applied for patent protection for two new drug formulations utilizing its proprietary excipient Zenergy™ .
Continuing high fuel costs and growing environmental pressures could inject new urgency into development of pulse-detonation engine (PDE) technology for wider commercial applications, rather than just ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback